enVVeno Medical Corporation carries a market capitalization of 176,731.00, placing it among publicly traded companies globally. Its enterprise value stands at -18.21M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 176,731.00 |
| Enterprise Value | -18.21M |
enVVeno Medical Corporation currently has 655,521.00 shares outstanding.
| Shares Outstanding | 655,521.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.03 |
| P/TBV Ratio | 0.26 |
| P/FCF Ratio | -0.41 |
| P/OCF Ratio | -0.41 |
enVVeno Medical Corporation maintains a current ratio of 11.89, meaning it holds 11.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 11.89 |
| Quick Ratio | 11.63 |
| Debt / Equity | 2.54 |
| Debt / EBITDA | -0.03 |
| Interest Coverage | N/A |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -56.45 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
enVVeno Medical Corporation's stock has declined approximately -91.80831% over the past 52 weeks. The 50-day moving average sits at 10.86, while the 200-day moving average is 18.87.
| Beta (5Y) | N/A |
| 52-Week Price Change | -91.80831% |
| 50-Day Moving Average | 10.86 |
| 200-Day Moving Average | 18.87 |
| Average Volume (20 Days) | N/A |
EBITDA reached -19.52M, while operating income came in at -20.01M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -20.01M |
| Pretax Income | -18.82M |
| Net Income | -18.82M |
| EBITDA | -19.52M |
| EBIT | -20.01M |
| Earnings Per Share (EPS) | -31.17 |
enVVeno Medical Corporation holds 24.93M in cash and equivalents against 603,000.00 in total debt, resulting in a net debt position of -2.60M. Total book value stands at -175.18M, with working capital of 23.35M providing operational flexibility.
| Cash & Cash Equivalents | 24.93M |
| Total Debt | 603,000.00 |
| Net Debt | -2.60M |
| Equity (Book Value) | -175.18M |
| Book Value Per Share | -290.13 |
| Working Capital | 23.35M |
enVVeno Medical Corporation produced -14.79M in operating cash flow over the past twelve months. After subtracting -5,000.00 in capital expenditures, free cash flow totaled -14.79M - equivalent to -24.50 per share.
| Operating Cash Flow | -14.79M |
| Capital Expenditures | -5,000.00 |
| Free Cash Flow | -14.79M |
| FCF Per Share | -24.50 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -16.73 |
| FCF Yield | -241.70 |
enVVeno Medical Corporation's most recent stock split took place on January 20, 2026 with a 35:1 split ratio.
| Last Split Date | 1/20/2026 |
| Split Ratio | 35:1 |
enVVeno Medical Corporation posts an Altman Z-Score of -9.29, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -9.29 |